BioSpace News Archive

Cortica Inc. (“Cortica”), a leading provider of advanced neurological therapies for children with autism, speech and language delays, sensory processing disorder and other conditions that impact brain development, held its official grand opening and ribbon-cutting ceremony yesterday, attended by representatives of the Carlsbad Chamber of Commerce

RAD Technology Medical Systems (RAD) is pleased to publicize their most recent TRV (Temporary Radiotherapy Vault) project at Community Howard Regional Health (Community Howard) in Kokomo, Indiana.

Alignment Healthcare, one of four “Best Insurance Companies” in 2020 for Medicare Advantage in the state of California by U.S. News & World Report, announced today a partnership with Welltok, an enterprise SaaS company, to support its ambitious growth goals.

NavaDerm Partners (“NavaDerm” or the “Company”), a Northeast-focused dermatology services company and portfolio company of BelHealth Investment Partners (“BelHealth”), a New York-based healthcare private equity firm, announced the appointment of Dr. John Murphy as Chief Executive Officer.

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NYSE: CGC) will release its financial results for the second quarter fiscal 2020 ended September 30, 2019 before financial markets open on November 14, 2019.

WaveForm Technologies Inc. a wholly owned subsidiary of AgaMatrix Holdings LLC and developer of novel continuous glucose monitoring products, today announced it has received CE Mark (Conformité Européenne) approval for its Cascade Continuous Glucose Monitoring (CGM) system.

The American Journal of Managed Care® (AJMC®), the leading multimedia peer-reviewed journal dedicated to issues in managed care, announced the agenda for the Patient-Centered Oncology Care® (PCOC) meeting that will take place on Nov. 8 at the Sofitel Philadelphia at Rittenhouse Square.

Medtronic plc (NYSE:MDT) today announced four-year data from the IN.PACT Global study, which reinforce the long-term durability and safety of the IN.PACT™ Admiral™ drug-coated balloon (DCB) in patients with peripheral artery disease (PAD) in the superficial femoral (SFA) and popliteal arteries.

Today, Boston Scientific (NYSE: BSX) announced positive data for two devices within the peripheral drug-eluting product portfolio during separate late-breaking clinical trial presentations at Vascular InterVentional Advances (VIVA) meeting in Las Vegas

Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) (“COOL” or the “Company”) is issuing this news release to clarify the terms of its definitive agreement to acquire Rainy Daze Cannabis, which was announced on November 4, 2019.